{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:51:54Z","timestamp":1792792314463,"version":"4.5.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Malignant pleural mesothelioma (MPM) is a rare type of cancer with a grim prognosis. So far, no targetable oncogenic mutation was identified in MPM and biomarkers with predictive value toward drug sensitivity or resistance are also lacking. Nintedanib (BIBF1120) is a small-molecule tyrosine kinase inhibitor that showed promising efficacy preclinically and in phase II trial in MPM as an angiogenesis inhibitor combined with chemotherapy. However, the extended phase III trial failed. In this study, we investigated the effect of nintedanib on one of its targets, the SRC kinase, in two commercial and six novel MPM cell lines. Surprisingly, nintedanib treatment did not inhibit SRC activation in MPM cells and even increased phosphorylation of SRC in several cell lines. Combination treatment with the SRC inhibitor dasatinib could reverse this effect in all cell lines, however, the cellular response was dependent on the drug sensitivity of the cells. In 2\u00a0cell lines, with high sensitivity to both nintedanib and dasatinib, the drug combination had no synergistic effect but cell death was initiated. In 2\u00a0cell lines insensitive to nintedanib combination treatment reduced cell viability synergisticaly without cell death. In contrast, in these cells both treatments increased the autophagic flux assessed by degradation of the autophagy substrate p62 and increased presence of LC3B-II, increased number of GFP-LC3 puncta and decreased readings of the HiBiT-LC3 reporter. Additionaly, autophagy was synergistically promoted by the combined treatment. At the transcriptional level, analysis of lysosomal biogenesis regulator Transcription Factor EB (TFEB) showed that in all cell lines treated with nintedanib and to a lesser extent, with dasatinib, it became dephosphorylated and accumulated in the nucleus. Interestingly, the expression of certain known TFEB target genes implicated in autophagy or lysosomal biogenesis were significantly modified only in 1\u00a0cell line. Finally, we showed that autophagy induction in our MPM cell lines panel by nintedanib and dasatinib is independent of the AKT\/mTOR and the ERK pathways. Our study reveals that autophagy can serve as a cytoprotective mechanism following nintedanib or dasatinib treatments in MPM cells.<\/jats:p>","DOI":"10.3389\/fcell.2022.852812","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T17:28:32Z","timestamp":1648488512000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Nintedanib and Dasatinib Treatments Induce Protective Autophagy as a Potential Resistance Mechanism in MPM Cells"],"prefix":"10.3389","volume":"10","author":[{"given":"Luca","family":"Heged\u00fcs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kata D.","family":"Sz\u00fccs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kudla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Jendrossek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Pe\u00f1a-Llopis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Garay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andras","family":"Czirok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Pl\u00f6nes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Vega-Rubin-de-Celis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balazs","family":"Heged\u00fcs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1158\/2159-8290.CD-19-0292","article-title":"Targeting Autophagy in Cancer: Recent Advances and Future Directions","volume":"9","author":"Amaravadi","year":"2019","journal-title":"Cancer Discov."},{"key":"B2","doi-asserted-by":"publisher","first-page":"101691","DOI":"10.1016\/j.isci.2020.101691","article-title":"c-Abl Inhibition Activates TFEB and Promotes Cellular Clearance in a Lysosomal Disorder","volume":"23","author":"Contreras","year":"2020","journal-title":"iScience"},{"key":"B3","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/JTO.0b013e318248242c","article-title":"Phase II Study of Dasatinib in Patients with Previously Treated Malignant Mesothelioma (Cancer and Leukemia Group B 30601): a Brief Report","volume":"7","author":"Dudek","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1757","DOI":"10.1038\/cddis.2015.124","article-title":"Inhibition of Autophagy Sensitizes Malignant Pleural Mesothelioma Cells to Dual PI3K\/mTOR Inhibitors","volume":"6","author":"Echeverry","year":"2015","journal-title":"Cell Death Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13046-017-0592-3","article-title":"Intrinsic Fluorescence of the Clinically Approved Multikinase Inhibitor Nintedanib Reveals Lysosomal Sequestration as Resistance Mechanism in FGFR-Driven Lung Cancer","volume":"36","author":"Englinger","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1002\/mc.23050","article-title":"Autophagy Facilitates the Release of Immunogenic Signals Following Chemotherapy in 3D Models of Mesothelioma","volume":"58","author":"Follo","year":"2019","journal-title":"Mol. Carcinog"},{"key":"B7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/mc.22757","article-title":"Inhibition of Autophagy Initiation Potentiates Chemosensitivity in Mesothelioma","volume":"57","author":"Follo","year":"2018","journal-title":"Mol. Carcinog"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1242\/jcs.188920","article-title":"Transcriptional Regulation of Mammalian Autophagy at a Glance","volume":"129","author":"F\u00fcllgrabe","year":"2016","journal-title":"J. Cel Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0117021","DOI":"10.1371\/journal.pone.0117021","article-title":"Prenylation Inhibition-Induced Cell Death in Melanoma: Reduced Sensitivity in BRAF Mutant\/PTEN Wild-type Melanoma Cells","volume":"10","author":"Garay","year":"2015","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1200\/JCO.2017.72.9012","article-title":"Nintedanib Plus Pemetrexed\/Cisplatin in Patients with Malignant Pleural Mesothelioma: Phase II Results from the Randomized, Placebo-Controlled LUME-Meso Trial","volume":"35","author":"Grosso","year":"2017","journal-title":"Jco"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1158\/0008-5472.CAN-07-6307","article-title":"BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy","volume":"68","author":"Hilberg","year":"2008","journal-title":"Cancer Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1038\/emboj.2013.133","article-title":"XIAP Inhibits Autophagy via XIAP-Mdm2-P53 Signalling","volume":"32","author":"Huang","year":"2013","journal-title":"EMBO J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/onc.2011.286","article-title":"New Pyrazolo[3,4-D]pyrimidine SRC Inhibitors Induce Apoptosis in Mesothelioma Cell Lines through P27 Nuclear Stabilization","volume":"31","author":"Indovina","year":"2012","journal-title":"Oncogene"},{"key":"B14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR Signaling in Growth Control and Disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1158\/1078-0432.CCR-17-1507","article-title":"Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo","volume":"24","author":"Laszlo","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1002\/cncr.25426","article-title":"Dasatinib Induces Autophagic Cell Death in Human Ovarian Cancer","volume":"116","author":"Le","year":"2010","journal-title":"Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","article-title":"Biological Functions of Autophagy Genes: A Disease Perspective","volume":"176","author":"Levine","year":"2019","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3389\/fphar.2020.00310","article-title":"Nintedanib Inhibits Wnt3a-Induced Myofibroblast Activation by Suppressing the Src\/\u03b2-Catenin Pathway","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-642-54490-3_2","article-title":"Dasatinib","volume":"201","author":"Lindauer","year":"2014","journal-title":"Dasatinib. Recent Results Cancer Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e29911","DOI":"10.4161\/mco.29911","article-title":"Chloroquine and Hydroxychloroquine for Cancer Therapy","volume":"1","author":"Manic","year":"2014","journal-title":"Mol. Cell Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"903","DOI":"10.4161\/auto.19653","article-title":"MTORC1 Functions as a Transcriptional Regulator of Autophagy by Preventing Nuclear Transport of TFEB","volume":"8","author":"Martina","year":"2012","journal-title":"Autophagy"},{"key":"B22","doi-asserted-by":"publisher","first-page":"6727","DOI":"10.3390\/ijms22136727","article-title":"Monosomy 3 Is Linked to Resistance to MEK Inhibitors in Uveal Melanoma","volume":"22","author":"Mergener","year":"2021","journal-title":"Ijms"},{"key":"B23","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1158\/1535-7163.MCT-08-0669","article-title":"Dasatinib-induced Autophagy Is Enhanced in Combination with Temozolomide in Glioma","volume":"8","author":"Milano","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12943-015-0392-3","article-title":"Targeting the Insulin-like Growth Factor Receptor and Src Signaling Network for the Treatment of Non-small Cell Lung Cancer","volume":"14","author":"Min","year":"2015","journal-title":"Mol. Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrm1549","article-title":"Focal Adhesion Kinase: in Command and Control of Cell Motility","volume":"6","author":"Mitra","year":"2005","journal-title":"Nat. Rev. Mol. Cel Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1056\/NEJMra2022774","article-title":"Autophagy in Human Diseases","volume":"383","author":"Mizushima","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"76577","DOI":"10.18632\/oncotarget.10428","article-title":"Dasatinib Modulates Sensitivity to Pemetrexed in Malignant Pleural Mesothelioma Cell Lines","volume":"7","author":"Monica","year":"2016","journal-title":"Oncotarget"},{"key":"B28","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41418-019-0474-7","article-title":"Autophagy in Cancer: Moving from Understanding Mechanism to Improving Therapy Responses in Patients","volume":"27","author":"Mulcahy Levy","year":"2020","journal-title":"Cell Death Differ"},{"key":"B29","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1083\/jcb.201501002","article-title":"MiT\/TFE Transcription Factors Are Activated during Mitophagy Downstream of Parkin and Atg5","volume":"210","author":"Nezich","year":"2015","journal-title":"J. Cel Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3389\/fonc.2019.01519","article-title":"Malignant Pleural Mesothelioma: State-Of-The-Art on Current Therapies and Promises for the Future","volume":"9","author":"Nicolini","year":"2019","journal-title":"Front. Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3389\/fonc.2020.00126","article-title":"Antiangiogeneic Strategies in Mesothelioma","volume":"10","author":"Nowak","year":"2020","journal-title":"Front. Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"14338","DOI":"10.1038\/ncomms14338","article-title":"mTORC1-independent TFEB Activation via Akt Inhibition Promotes Cellular Clearance in Neurodegenerative Storage Diseases","volume":"8","author":"Palmieri","year":"2017","journal-title":"Nat. Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1038\/emboj.2011.257","article-title":"Regulation of TFEB and V-ATPases by mTORC1","volume":"30","author":"Pe\u00f1a-Llopis","year":"2011","journal-title":"EMBO J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1101\/gad.325514.119","article-title":"Role of Tumor and Host Autophagy in Cancer Metabolism","volume":"33","author":"Poillet-Perez","year":"2019","journal-title":"Genes Dev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e98804","DOI":"10.15252\/embj.201798804","article-title":"The Complex Relationship between TFEB Transcription Factor Phosphorylation and Subcellular Localization","volume":"37","author":"Puertollano","year":"2018","journal-title":"EMBO J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1172\/JCI20039","article-title":"Promotion of Tumorigenesis by Heterozygous Disruption of the Beclin 1 Autophagy Gene","volume":"112","author":"Qu","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1165\/rcmb.2014-0445OC","article-title":"Novel Mechanisms for the Antifibrotic Action of Nintedanib","volume":"54","author":"Rangarajan","year":"2016","journal-title":"Am. J. Respir. Cel Mol Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1470-2045(13)70586-2","article-title":"Docetaxel Plus Nintedanib versus Docetaxel Plus Placebo in Patients with Previously Treated Non-small-cell Lung Cancer (LUME-Lung 1): a Phase 3, Double-Blind, Randomised Controlled Trial","volume":"15","author":"Reck","year":"2014","journal-title":"Lancet Oncol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"175346661880061","DOI":"10.1177\/1753466618800618","article-title":"Nintedanib in the Management of Idiopathic Pulmonary Fibrosis: Clinical Trial Evidence and Real-World Experience","volume":"12","author":"Rivera-Ortega","year":"2018","journal-title":"Ther. Adv. Respir. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"ra42","DOI":"10.1126\/scisignal.2002790","article-title":"The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome Homeostasis","volume":"5","author":"Roczniak-Ferguson","year":"2012","journal-title":"Sci. Signal."},{"key":"B41","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.1174447","article-title":"A Gene Network Regulating Lysosomal Biogenesis and Function","volume":"325","author":"Sardiello","year":"2009","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S2213-2600(19)30139-0","article-title":"Nintedanib in Combination with Pemetrexed and Cisplatin for Chemotherapy-Naive Patients with Advanced Malignant Pleural Mesothelioma (LUME-Meso): a Double-Blind, Randomised, Placebo-Controlled Phase 3 Trial","volume":"7","author":"Scagliotti","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.1204592","article-title":"TFEB Links Autophagy to Lysosomal Biogenesis","volume":"332","author":"Settembre","year":"2011","journal-title":"Science"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/emboj.2012.32","article-title":"A Lysosome-To-Nucleus Signalling Mechanism Senses and Regulates the Lysosome via mTOR and TFEB","volume":"31","author":"Settembre","year":"2012","journal-title":"EMBO J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/ijc.2910410210","article-title":"Monoclonal Antibodies against Mesothelial Membrane Antigen Discriminate between Malignant Mesothelioma and Lung Adenocarcinoma","volume":"41","author":"Stahel","year":"1988","journal-title":"Int. J. Cancer"},{"key":"B46","doi-asserted-by":"publisher","first-page":"100750","DOI":"10.1016\/j.bbrep.2020.100750","article-title":"Comparison of Autophagy Inducibility in Various Tyrosine Kinase Inhibitors and Their Enhanced Cytotoxicity via Inhibition of Autophagy in Cancer Cells in Combined Treatment with Azithromycin","volume":"22","author":"Tanaka","year":"2020","journal-title":"Biochem. Biophys. Rep."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1158\/1535-7163.MCT-07-0052","article-title":"Inhibition of C-Src Expression and Activation in Malignant Pleural Mesothelioma Tissues Leads to Apoptosis, Cell Cycle Arrest, and Decreased Migration and Invasion","volume":"6","author":"Tsao","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jtho.2017.10.033","article-title":"Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma","volume":"13","author":"Tsao","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1021\/bi902135e","article-title":"Structural Analysis and Functional Implications of the Negative mTORC1 Regulator REDD1,","volume":"49","author":"Vega-Rubin-de-Celis","year":"2010","journal-title":"Biochemistry"},{"key":"B50","first-page":"361","article-title":"Autophagy in Cancer, Friend of Foe?","volume-title":"Autophagy in Health and Disease","author":"Vega-Rubin-de-Celis","year":"2021"},{"key":"B51","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1080\/15548627.2016.1271514","article-title":"Multistep Regulation of TFEB by MTORC1","volume":"13","author":"Vega-Rubin-de-Celis","year":"2017","journal-title":"Autophagy"},{"key":"B52","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1073\/pnas.1717800115","article-title":"Increased Autophagy Blocks HER2-Mediated Breast Tumorigenesis","volume":"115","author":"Vega-Rub\u00edn-de-Celis","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B53","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1126\/science.1225967","article-title":"Akt-mediated Regulation of Autophagy and Tumorigenesis through Beclin 1 Phosphorylation","volume":"338","author":"Wang","year":"2012","journal-title":"Science"},{"key":"B54","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-1-0716-2071-7_6","article-title":"A Dual Lentiviral Reporter for Autophagy Flux Assessment","volume":"2445","author":"Will","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s40262-019-00766-0","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib","volume":"58","author":"Wind","year":"2019","journal-title":"Clin. Pharmacokinet."},{"key":"B56","doi-asserted-by":"publisher","first-page":"626309","DOI":"10.3389\/fonc.2021.626309","article-title":"Targeting Cytoprotective Autophagy to Enhance Anticancer Therapies","volume":"11","author":"Xiao","year":"2021","journal-title":"Front. Oncol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41419-021-03668-x","article-title":"Malignant Pleural Mesothelioma Co-opts BCL-XL and Autophagy to Escape Apoptosis","volume":"12","author":"Xu","year":"2021","journal-title":"Cel Death Dis"},{"key":"B58","doi-asserted-by":"publisher","first-page":"25543","DOI":"10.1073\/pnas.2007622117","article-title":"Asbestos Induces Mesothelial Cell Transformation via HMGB1-Driven Autophagy","volume":"117","author":"Xue","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.852812\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T17:28:38Z","timestamp":1648488518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.852812\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":58,"alternative-id":["10.3389\/fcell.2022.852812"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2022.852812","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"article-number":"852812"}}